John Rozembersky's Bio

I found John's web site and was browsing around:
http://www.rozemberskygroup.com/

Here is his BIO:

John Rozembersky is CEO &
President of The Rozembersky
Group, Inc.

The mission for this firm is to be a
dedicated and total tangential flow
filtration (TFF) solutions provider to
the biopharmaceutical applications
market. John is internationally
recognized as a leading authority
for TFF in the Life Science
market. His hands-on experience
and in-depth knowledge for
filtration and purification, built over
the past 30+ years, spans process
applications from bench top to
large scale manufacturing.

Previously, John Rozembersky was
co-founder of a successful TFF
company, Filtron Technology
Corporation. For 10 years, Filtron
grew from a start-up company to a
$15 million worldwide leader in TFF
providing membrane products with
developed leading-edge
technologies. John’s initial
contribution as a founder was the
development of the core membrane
process and membrane chemistries
that produced the most extensive
line of UF and MF membrane TFF
products available by any one
manufacturing company.

In 1995, Filtron was acquired by
Pall Corp. and John remained on
as VP of Application and Technical
Support. His responsibilities
included directing technical support
and TFF technology transfer for
customers’ downstream purification
processes.
Throughout his career, John
focused his attention and resources
to defining, characterizing and
trouble-shooting scores of
applications in tangential flow
filtration in the pharmaceutical and
biotechnology markets. These
applications included: plasma
fractionation, vaccines, recombinant
proteins and cell harvesting
applications. He played a major role
in the design and installation of
complete sanitary process systems
for both upstream and downstream
purification schemes in the industry.
John supported, and often designed,
the validation process plans for TFF
necessary for the FDA approvals.
John is an esteemed lecturer on
topics covering all aspects of applied
principles and techniques used for
tangential flow filtration in biopharm
applications.

John’s experience in membrane
filtration and downstream purification
started where he began his
membrane-technology career with
Millipore. John was responsible for
membrane process development for
products that included both RO and
MF. After Millipore and before
launching Filtron, John worked at
Waters Associates as Director of
Engineering with responsibilities for
the process development and
technical support of the Chemical &
Media Division for Water’s high
performance chromatography
product line.

John completed both his BS and MS
studies in Chemical Engineering at
the New Jersey Institute of
Technology.